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Background: In light of the recent debate on the use of financial incentives to promote long-acting contraception
and sterilisation among women who use illicit drugs we discuss attitudes to contraception, pregnancy and
parenting among Australian women who inject drugs.
Methods: Qualitative interviews were conducted with 90 women of reproductive age about contraceptive use,
preferences, reproductive histories, attitudes to and experiences of parenting. All women were either currently, or
had previously injected drugs. The in-depth, semi-structured interviews were compared and contrasted for themes
relating to drug use, contraception, pregnancy and parenting.
Results: Participants aspired to control their fertility, expressed individual contraceptive preferences and concerns
for their children (both born and unborn). Most had tried a number of contraceptive methods interspersed by
periods of non-use related to experiences of side-effects, being single or abstinent, believing that they were infertile
and trying to conceive. Attitudes varied from woman to woman and in the same individual over their life course.
Some believed that they were not likely to be capable, but most aspired to be successful mothers.
Conclusions: Women’s drug use should not automatically be associated with an inability to make informed health
care choices or to care for children. Evidence suggests that women who use drugs do not need to be paid to limit
or end their fertility. Rather, programs that aim to reduce barriers to obtaining free, non-discriminating reproductive
advice and parenting assistance would better utilise women’s agency to improve their own reproductive health.Background
Periodically, public alarm is raised about the potential
negative impact of women’s drug use on children’s health
and well-being. This occurred recently in Australia driven
by the possible introduction of a controversial privately
funded program, Project Prevention [1]. Operating in the
USA and the UK the program pays women who use alco-
hol and/or other drugs US$300 (UK£200) to be sterilised
or take long-acting contraception. While the program ad-
dresses men and women who use alcohol or other drugs,
its emphasis is on women. According to public statements
(see http://www.projectprevention.org/) the aims of Pro-
ject Prevention are 1) to prevent or reduce the number of
children born that are affected by drugs and 2) to prevent
women from having children who are deemed to be un-
able to care for them because of their drug use. The pro-
gram’s underlying rationale is that people who use alcohol* Correspondence: aolsen@kirby.unsw.edu.au
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reproduction in any medium, provided the orand other drugs are both incapable of making appropriate
decisions about their fertility and caring for children.
In a recent visit to Australia the program’s founder,
Barbara Harris, told the Age newspaper that if funding
is obtained she expects to bring the program to
Australia (http://www.theage.com.au/national/charity-
preys-on-weak-addicted-20101019-16sjp.html). No de-
tails were provided on its proposed format, but it is
likely that if it were introduced, it would replicate the
US program in which participants provide evidence of
their long–term drug use and medical evidence of the
sterilization or long-term contraception implantation
before receiving payment.
Objectors to Project Prevention have criticised the pro-
gram for isolating a specific population of people, especially
low-income, minority women, for fertility control and
contravening basic human rights [2-7]. As the program of-
fers a single service – reproductive control to people who
use drugs – without aims to assist or improve other health
or social needs such as dependency, long-term economictd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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compared with eugenic movements. In the social sciences
the aims and objectives of Project Prevention have been
used to explore neoliberal discourses of female drug users
as ‘risky’ reproductive agents and the neo-liberal governing
of (pregnant) bodies by state and non-state agencies [8].
With respect to incentivising health behaviours, there is
increasing interest in international development, public
health, and clinical medicine as to whether cash payments
or other economic incentives can be used to influence the
choices and behaviours of individuals and groups in order
to promote desired health goals [9]. Some evidence sug-
gests that prizes and other incentives can encourage
people to make short-term behavioural changes such as
smoking cessation [10]. However, experts have also noted
the need to address the potential for the coercive effect of
incentives on patient autonomy. Many objectors to Project
Prevention have argued that using comparatively large fi-
nancial gifts to discourage economically disadvantaged
people who use drugs from having children is morally and
ethically inappropriate [2-4,6,11,12].
Programs such as Project Prevention draw attention to
the complex and, in some cases, unresolved health and so-
cial issues regarding women’s illicit drug use, reproduction
and parenting. Evidence for poor reproductive health out-
comes among women who inject drugs is varied. Unin-
tended pregnancies are often reported to be high [13] as
well as high pregnancy rates and high rates of adverse
pregnancy outcomes (miscarriage, termination and still-
birth) [14]. However, these findings are often not com-
pared with national averages where unintended pregnancy
and termination rates in the general population are also
considered high [15,16].
Clinical data suggests that heroin use during pregnancy
contributes to poor maternal and child outcomes and
causes an increase in obstetric complications [17] as well
as neonatal complications [18,19]. However, meta-analyses
have shown that social disadvantage and tobacco use are
often not considered in analyses [20,21]. Such potential
confounders are rarely considered for their possible con-
tributions to poor neonatal outcomes.
As reflected in the aims of Project Prevention, concern
about the health and well-being of children whose parents
use drugs is widespread. Children of people who use drugs
are considered to be at risk of neglect and abuse [22,23]
and parental drug use is increasingly seen as a factor in
child protective service provision [23,24]. It is, however,
acknowledged that the nature of any relationships between
substance use and child-rearing are complex, and that
poverty and psychological disorders are contributing fac-
tors to poor child outcomes [25].
Challenging simplistic cause and effect associations, a
small body of literature cautions against conflating parental
drug use with child neglect [26]. In particular, sociologicalresearch shows that mothers who use drugs often feel cap-
able as parents, place a high value on motherhood and
hold strong ideals around childrearing [27-29]. Further,
barriers to fertility control, rather than a lack of agency in
making health decisions, may explain poor health out-
comes in this population [30].
In terms of Australia’s response to drug use, policies are
guided by a harm minimisation framework. Rather than
explicitly punitive approaches, specialised drug support
and pre and post natal services are available for the 1.3%
to 2% of women who use illicit drugs during pregnancies
in Australia [23,31]. Pregnancy is seen as an ideal time to
involve women in the health care system and, despite
prejudice displayed by some health care professionals to-
wards people who use drugs [32-34], pregnant women can
be highly motivated to engage in health care provision
such as opioid substitution therapy [35]. Stable use of opi-
oids, such as methadone maintenance, during pregnancy
reduces maternal illicit opiate use and fetal exposure, en-
hances interaction with obstetrical care, and is associated
with improved neonatal outcomes like heavier birth weight
[17,18,36].
Many (but not all) contraceptive methods and brands
are available on the Australian Pharmaceutical Benefits
Scheme, making them low cost for women eligible for
government assistance. Yet, little is known about contra-
ceptive use among Australian women who inject drugs.
Surveys suggest that they have a lower level of contracep-
tion use than the general population. Approximately 60%
of all Australian women aged 18 to 44 use contraception
[37]. Lower levels have been reported among women who
use drugs – between 34% [38] and 54.7% [14] – yet this
survey data may not be useful in describing the intentions
of a particular woman at any point her reproductive life.
Behaviours around sex and pregnancy intendedness are
emotional, inter-personal and contextual and cannot be
easily measured by surveys and scales [39-41]. In other
words, survey data should be interpreted cautiously when
applied to population level health data and interventions.
In light of interest in Project Prevention in Australia and
conflicting evidence on the reproductive health choices of
women who use drugs we seek to provide an in-depth and
nuanced picture of contraceptive use, pregnancy and moth-
ering by Australian women with a history of injecting drug
use. We draw on empirical evidence to discuss whether the
underlying assumptions made by Project Prevention about
women who use drugs are valid and whether the program
would be appropriate to the Australian context. Elucidating
women’s attitudes and experiences, we discuss health care
priorities for this population and their children.
Methods
During 2005–06 in-depth, semi-structured interviews
were conducted with 109 women who were currently
Table 1 Socio-demographic characteristics
N = 90
Age in years Range 17-45 Mean 32
N %
Education
Attended tertiary education 8 8
Completed Yr 11 + 12 25 28
Employment
Employed part-time, full-time, casual 14 15
Relationship status
Single, separated, widowed, divorced 35 39
In a relationship, de facto,
long-term boyfriend, married
55 61
Household income
<$20,000 73 81
Assets
Receiving benefits 82 91
Owns a car 25 28
Owns a home 6 7
Children
Number of women with at least
one child living with them
68 75
Justice system
Ever remanded in custody or jailed 35 39
Drug use
Injected drugs in the last 12 months 83 92
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hepatitis C positive. Data from a sub-sample of women of
reproductive age, aged 45 years or younger (n = 90), have
been extracted for this paper. We employed a purposive
sampling framework in order to represent women from a
range of socio-economic backgrounds. We recruited inter-
viewees from community organisations such as HCV
councils, peer-based organisations for people who inject
drugs, drug treatment services, and health clinics in two
urban cities in Australia: Canberra and Melbourne. Ethical
approval was received from the Australian National
University Human Research Ethics Committee and writ-
ten consent was received from all participants.
A brief, standardized set of questions was used to collect
socio-demographic data followed by open-ended questions
on past and current contraceptive experiences, drug use
histories, reproductive and sexual health, hepatitis C re-
lated health, current living arrangements, and future plans.
Interviews were digitally recorded and professionally tran-
scribed. Qualitative data were entered into Atlas.ti [42].
Preliminary analysis of the qualitative data was guided by
themes from the research literature and interview questions
related to reproduction, contraception, hepatitis C and drug
use. Specific experiences within these topics were compared
and contrasted while new themes such as poverty, housing
and concerns about children emerged. For each theme
identified, transcripts were re-read and re-coded, systemat-
ically comparing interviews in order to build links between
themes and condense any that overlapped. The research
team jointly reflected on the conduct and content of inter-
views. Pseudonyms are used throughout.
As this is a relatively large qualitative study across two
metropolitan cities in Australia we believe that the find-
ings are relevant to other Australian women who inject
drugs. While we find similarities between this data and
findings from research conducted internationally, the dif-
ferent country approaches to health care provision and
policy means that direct comparison may not be valid.
One potential limitation of our Australian findings is that
women were recruited from health care centres, hepatitis
C councils and peer-based organisations for people who
inject drugs suggesting that they already seek and receive
health care. It is not clear whether their experiences differ
from women who do not use these services; it is possible
that women who are not in regular contact with health
services use contraceptives less and hold different atti-
tudes to drug use and child bearing.
Results
The primary illicit drug of use amongst participants was
heroin, although amphetamine, benzodiazepine and other
opiate injection was also reported. Most women were dis-
advantaged with achieved education levels of Year 10 or
lower and an annual household income of less than$20,000 per annum (See Table 1). Women frequently de-
scribed struggling to make ends meet between welfare in-
come and payments for housing, food, children’s items,
and drugs.
Contraception use by 90 women of reproductive age is
shown in Table 2. Over half of the women (60%) reported
that they did not use contraception in the last 12 months,
five of whom were pregnant or were trying to conceive.
Twelve women were using long-acting contraceptive
methods. Several women reported using condoms as well
as other contraception.
Contraceptive use
The paid provision of contraception by Project Prevention
is limited to a small number of permanent or long-acting
methods currently on the market (male and female steril-
isation, intrauterine devices (IUDs) and Implanon). Easily
reversible and user-controlled contraception (eg hormonal
pill, NuvaRing, diaphragm, condoms and spermicides) are
not supported by the program and the long-acting method
Depo-provera is no longer supported. In order to elucidate
women’s experiences of contraception and the implications
a particular method can have on her life trajectory, we
Table 2 Contraception used in the past 12 months
N = 90
None
No contraceptive use
(includes abstinence, withdrawal, celibacy)
49
Pregnant or trying to get pregnant 5
Permanent methods
Tubal ligation, partner vasectomy 6
Long-acting methods
Implanon 6
Depo 5
IUD 1
Reversible methods
The pill 4
Condoms 17*
Diaphragm 0
*Condoms were sometimes used in conjunction with other contraceptives.
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tion: (1) permanent sterilisation (2) long-acting methods (3)
easily reversible methods and (4) non-use.
Sterilisation
Six women in our study reported having had a tubal
ligation or that their male partner had had a vasectomy.
Some women had resorted to tubal ligation early in their
lives to escape the risk of pregnancy during a period of
heavy drug use. Reflecting on her past drug use, Diane,
who was in her mid-forties, illustrates the multiple con-
textual factors that many women take into account when
considering this option. Her account contradicts the no-
tion of the irresponsible drug-user and demonstrates her
many efforts to manage her fertility.
I was twenty-one and I was pretty full on into dope. I
was homeless. I was living in Sydney just at people’s
places. I thought my life was not going to work out and
I was always going to be an addict. Even though I
didn’t want to be I just thought that’s the path I’m go-
ing and I can’t see any way out. I had terrible prob-
lems with IUD. I had rotten experiences with the pill. I
didn’t trust condoms as a form of contraception and
one of my mates said, ‘Have your tubes tied’, I just did.
Long-acting methods
Most women in this sample had preferred to keep their re-
productive options open. At the time of the interview 12
were using long-acting hormonal contraceptives (IUD,
Implanon or Depo Provera). In addition to fertility control,
these methods were chosen because women were not re-
quired to remember to take a daily tablet (the pill), and be-
cause of their side-effects of reduced or no menstruation.In contrast to sterilisation, long-acting methods also
allowed for pregnancy in the future. For example, Rebecca,
a 23 year old, chose Depo Provera because she aspired to
a ‘normal’ life in the future that included a stable relation-
ship and healthy and happy children.
I’d like to have a child but I want to do the right
thing by the child too. I want to try and be the best
parent I can be. I don’t mind if I don’t have the child
until I’m 30 or however it works out. I might not even
have children, it might not work out that way, but at
the moment I don’t think I could look after a child to
the best of my ability or to what the child deserves.
So it’s better safe than to be sorry so that’s why I just
get the injections (Depo Provera) instead of using
a condom.
In the details of their reproductive histories many
more women reported previously trying a long-acting
hormonal contraceptive but ceasing when they wanted
to get pregnant, ended a relationship, method failure
or, commonly, when they experienced unpleasant side
effects such as menstrual irregularities. Sam, a 30 year
old, recounts how her attempt to responsibly manage
her “lifestyle” was thwarted:
Yes, that [implant] was horrible. My sisters
recommended it, they both had had it. Because I was
living the [drug-using] lifestyle that I was I thought it
would be a good idea to get the implant, but I kept
bleeding all the time with it.
Easily reversible methods
In our study four women were using the hormonal pill but
most women had used it at one point of their reproductive
lives. The hormonal pill was often one of the first methods
of pregnancy prevention or was used to regulate menstru-
ation. Women’s rationales for giving up the pill included:
change in relationship status, side effects, to “give their
body a break” from the synthetic hormones, or because of
method failure (unplanned pregnancy).
For example, when Imogen, 30 years old, was younger
she found that the pill caused her to menstruate con-
tinuously for six months and saw this as evidence of the
dangers of contraception. The experience was linked to
stopping that contraception and a subsequent unplanned
pregnancy.
… and I had the pill, tablets when I was a teenager
and I just bled the whole time … The whole six
months I just bled. I couldn’t handle it and when I
stopped taking the pill it was like I didn’t bleed for two
months and then I was pregnant … It just stuffs
around the body too much that kind of crap.
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conjunction with other methods. Although, women gener-
ally talked about the condom as a method for preventing
sexually transmissible infection (STI) rather than preg-
nancy. Condoms were often used during casual sex or at
the beginning of a relationship when the couples’ STI status
was unknown. Once an STI test had been performed, con-
dom use became irregular or stopped within that relation-
ship and was not always replaced by other contraceptives.
Clara, 33 years old, had experimented with several
methods of contraception ending in intermittent condom
use. Her contraceptive career was punctuated by un-
planned pregnancies, two of which were terminated.
… tried them all, actually, all. None of them work … I
found I experimented with different contraception, like,
the injection, the pill, and I had found that nothing
had seemed to - I couldn’t take anything … The injec-
tion made me vomit continuously. Really badly. And
the pill just made me feel sick all the time. So, when I
started working at prostitution when I was about nine-
teen, so after that it was just condoms.
Non-use of contraception
Over half of the sample (60%) reported no current contra-
ceptive use. Five of these women were pregnant or were
trying to get pregnant. A few women blamed themselves
for not being organised enough to use contraception while
others provided logical reasons for not doing so including:
not being able to find a method that they were comfort-
able using; concerns about the negative effects of contra-
ception on long-term fertility; being abstinent or single;
not expecting to have sex; or only having sex with women.
As we have discussed elsewhere, some were disinterested
in sex due either to previous abusive relationships or a
lowered libido which can come with opiate use [43,44]. A
few women considered their use of the withdrawal or the
rhythm methods as contraception although these methods
are not widely recognised as effective.
Many interviewees’ reproductive histories reflected in-
tervals when they did not use contraception despite sex-
ual activity and not wanting to get pregnant. A common
reason provided for non-contraceptive use was the belief
that they were infertile as a result of their drug use; a be-
lief arising from their experience of amenorrhea or dys-
menorrhea. As Vanessa, 29 years old, explains, women
frequently understood lack of menstruation as infertility.
I was on the methadone programme last year for ten
months and I didn’t get a period then. I thought that
was a form of contraception but I was mistaken … I
went to the hospital and they said [I was] pregnant
and I was in shock. It was wrong timing. I was
thinking of joining the army reserve and getting work. Ihad my life planned out for the next five years and
then the pregnancy happened and that just threw
everything out of whack. Now I have accepted and I
am doing my best to make sure that I can provide for
this child and that.
Pregnancy & motherhood
Patterns of contraceptive use and attitudes to contraception
were also intertwined with women’s experiences of, and
hopes for, their fertility. Contraception could allow one to
fulfil aspirations of being a responsible woman. However
complete or satisfactory fertility control was regularly re-
ported to be difficult to achieve and contraceptive needs
could be overtaken by other aspects of their lives. Many
women had experienced unplanned pregnancies and termi-
nations, sometimes several. Yet the narratives women used
to describe these experiences suggest more than hapless,
out of control bodies.
They were, for example, aware of the potential damage
to their children, born and unborn, of drug use and other
aspects of their lives. They often commented negatively
about combining drug use with pregnancy and parent-
hood and aimed to refrain from having children until they
no longer used drugs or their use was more stable. Several
younger women revealed plans for controlling their
reproduction now, while aspirations of parenthood lay in
the future. They discussed ideals of how and when they
wanted to become a mother, what type of motherhood
they aimed to realise as well as changes to their drug use
and economic independence.
The prospect of motherhood (both planned and un-
planned) provided some women with an incentive to stop
using drugs or to go onto treatment. As Christine, a 28
year old single mother and a previous injecting drug user,
described:
Because it really gave me the strength that I don’t know I
would have had otherwise, to pull myself out of a pretty
bad lifestyle, pretty bad head space, the whole situation
that I was in for a while. It sort of gave me that
understanding that some things are more important.
Others felt that they had successfully reconciled
motherhood and drug dependency. They attempted to
shield their children from any ill-effects of their drug
use by setting aside money and hiding their drug use.
Pam, 33 years old, a mother of two and expecting a
third child made the point: you can be a heroin addict
and have kids - you get money the first thing you’ve got
to do is make sure your kids are alright; make sure
they’re fed, they’re warm and that.
Similarly, Julianne, a 39 year old with a troubled history
of drug use, sex work and domestic violence described the
success and independence of her children.
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Year Twelve and done all their studies and went to
college … They have done all that at their young age
and I am so proud of them. They didn't turn out like
me. It wasn't in my blood to go and have drugs.
Still, many women were not in custody of their children
who had been adopted out, were cared for by family mem-
bers or had been removed by government services. Some
women were trying to regain custody of their children,
others had accepted the judgement that they were inad-
equate mothers for these children, or for any further chil-
dren, because of their drug use. Children were usually
removed involuntarily, although several women reported
relinquishing care of their children when issues related to
drug use became insurmountable. They perceived this
agreed child removal as a form of good mothering, albeit
undesirable and painful. Roseanne, a 27 year old in a de
facto relationship, had recently placed her youngest child
in foster care.
I was living on my own with my son. I had my son
with me, and then I put him in foster care when he
was fourteen months old. The biggest mistake I ever
done, but it was the best thing for him anyway.
Discussion
These descriptions of contraception, pregnancy and moth-
ering are mixed and at times ambivalent. Despite this, in-
terviewees’ voices express agency, purpose and hope and
provide a nuanced picture of women’s attitudes and be-
haviours, and thus health care needs, of Australian women
who inject drugs. Our analysis addresses, in the Australian
context, the main concerns driving Project Prevention: the
assumption that people who use drugs, particularly
women, do not have the capacity, facility or agency to en-
gage contraceptive methods without considerable incen-
tive; and that they are not suitable parents.
This study demonstrates first that women who inject
drugs are capable of organising permanent, long-acting
and reversible contraception. Like women in the general
population [37,45,46], women who inject drugs provided
an array of reasons for stopping and starting various
contraceptive methods at different times [43,44]. Some re-
ported regular contraceptive use while most described a
history in which they used one form of contraception after
another interspersed by a lengthy hiatus. At different
stages of their lives and drug histories women reported
recognising that their ability to parent a child was threat-
ened and drug use itself could also be a primary motivator
for contraceptive use, or more exceptionally, sterilization.
Reasons for not using contraception at a particular time
were diverse and meaningful and included: experience of
side-effects, being single, believing that they wereinfertile, trying to conceive and being pregnant. Despite
being highly sexualised in much of the literature,
women also discussed abstinence, disinterest in sex and
lowered libido [43,44] as reasons for non-use or irregu-
lar use of contraception. This data reveals a more nu-
anced picture of the sexual and reproductive behaviours
of women who use drugs. Rather than out-of-control
bodies, interviewees describe making choices and report
many of the same reproductive experiences as other
women bringing into question the underlying assump-
tions of Project Prevention and the appropriateness of
the intervention in the Australian context.
Second, this research provides a more nuanced picture
of pregnancy and parenting among women who use drugs
than common risk-based analyses or survey research. As-
sumptions made about women’s parenting capabilities ig-
nore the evidence that they can be capable of providing a
nurturing and loving environment for their children
[47,48] even in the midst of injecting drug use and eco-
nomic insecurity [29,49-52]. Some women we interviewed
had lost children to social services and expressed doubts
about their capacity to parent. However, most women as-
pired to be successful parents and those caring for chil-
dren described actively working to prevent harm to their
children. This echoes other research which suggests that
women can modify, decrease or cease their drug use in re-
sponse to contextual factors, including children and re-
sources [48,51] and shows that they can recognise when
they need help with parenting [26].
Together, these findings highlight women’s agency in
making health decisions [30] and bring into question a
number of Project Prevention’s more-punishment based
objectives. In particular, we suggest that there are alter-
native approaches to Projection Prevention that better
fit within a harm reduction approach to illicit drug use.
For example, free contraceptive advice and availability
accepts that women who use drugs value motherhood,
can plan pregnancy and value reproductive health infor-
mation (as opposed to preventing their child-bearing
through incentivisation).
Currently all contraceptive devices, other than condoms,
are prescribed and/or inserted by health care professionals
in Australia so any response to improving contraceptive
up-take and reproductive advice for women who use
drugs will require the availability of easily accessed, non-
discriminatory services. Within the health care system,
stigma and discrimination towards people who inject
drugs is shown to negatively impact on their accesses to
quality service provision [32,53,54]. Health services pro-
viding information and access to contraception must ad-
here to principles including informed consent, respect for
each patient, bodily integrity and the right to refuse med-
ical treatment [4,5] which do not easily fit with the objec-
tives of Project Prevention.
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and policy discourse should be concerned with treatment
and holistic care, rather than prevention of procreation.
Currently Australians who use drugs report barriers to
drug treatment access including long waiting times, lack of
support and childcare concerns [55,56]. More broadly,
many people who use illicit drugs in Australia experience
disadvantage with respect to general health, co-morbidities
and economic poverty [57,58]. Socio-economic difficulties
experienced by parents and families [27,59], including the
emotional and social impact of stigma, marginalisation and
demoralisation [60-63] need to be considered alongside
health care policy and practice.
Finally, there are practical and ethical differences be-
tween offering services that will pay for contraception, in-
cluding sterilisation if the individual prefers this method,
and paying women to control their fertility. Incentivised
or openly coercive contraceptive schemes “embody the er-
roneous premise that low income women are not compe-
tent to make their own contraceptive decisions… only to
strip low income women of their dignity and decisional
autonomy” [4]. Particularly when it comes to drug use,
pregnancy and parenting, “the mother’s needs disappear
and they are only considered for the harms they transmit
to their children” [27]. In targeting only the reproductive
capacity of some women, Project Prevention fails to ad-
dress women's needs for comprehensive reproductive
health care, effective drug treatment programs, mental
health services, and social, economic and educational sup-
port. Rather than fixing any particular social or population
health problem, such openly targeted programs are ethic-
ally questionable, only serve to punish and further margin-
alise people who use drugs, especially women, [64] and fail
to utilise their agency to improve their own health and
that of their family.Conclusion
Empirical evidence suggests that women who inject
drugs are capable of organising permanent, long-acting
and reversible contraception and do not need to be paid
to limit or end their fertility. Further, that parental drug
use is not synonymous with child abuse. Broader cri-
tiques of the neo-liberal governing of pregnant bodies
also highlight the ethical problems associated with tar-
geting certain women for reproductive control. Rather,
than punishing women for their drug use, health pro-
grams that aim to reduce barriers to obtaining free,
non-discriminating reproductive advice and parenting
assistance would better utilise women’s agency to im-
prove their own reproductive health.Competing interests
The authors declare no completing interests.Authors’ contributions
AO and CB participated in the design of the study, data collection, analysis
and drafting of the manuscript. AM participated in the drafting of the
manuscript. All authors read and approved the final manuscript.Acknowledgments
We gratefully acknowledge the financial support of the National Health and
Medical Research Council who funded this research. Our sincere thanks to
the women who shared their stories with us, our colleague Dr Phyll Dance,
the Australian Injecting and Illicit Drug Users League (AIVL) and the Canberra
Alliance for Harm Minimisation and Advocacy (CAHMA).
Author details
1The Kirby Institute, The University of New South Wales, Sydney, Australia.
2National Centre for Epidemiology and Population Health, The Australian
National University, Canberra, Australia. 3The Australian Injecting and Illicit
Drug Users League (AIVL), Canberra, Australia.
Received: 9 July 2013 Accepted: 27 December 2013
Published: 9 January 2014References
1. Lucke JC, Hall WD: Under what conditions is it ethical to encourage
drug-using women to use long-acting forms of contraception?
Addiction 2012, 107:1036–1041.
2. Johnson J: Reproductive ability for sale, do I hear $200? private cash-for-
contraception agreements as an alternative to maternal substance
abuse. Ariz Law Rev 2001, 43:205–243.
3. Mauldon JG: Providing subsidies and incentives for Norplant, sterilization
and other contraception: allowing economic theory to inform ethical
analysis. J Law Med Ethics 2003, 31:351+.
4. Mertus J, Heller S: Norplant meets the new eugenicists: the
impermissibility of coerced contraception. Saint Louis Univ Publ Law Rev
1992, 11:359–383.
5. Moskowitz E, Jennings B, Callahan D: Long-acting contraceptives ethical
guidance for policymakers and health care providers. Hast Cent Rep 1995,
25(1):S1–S8.
6. Paltrow LM: Is it ethical to suggest that some women need incentives to
use contraception or to be sterilized? Addiction 2012, 107:1047–1049.
7. Thompson MS: Contraceptive implants: long acting and provider
dependent contraception raises concerns about freedom of choice.
BMJ 1996, 313(7069):1393–1395.
8. Gregory J: (M)Others in altered states: prenatal drug-use, risk, choice, and
responsible self-governance. Soc Legal Stud 2010, 19(1):49–66.
9. London AJ, Borasky DA, Bhan A: Improving ethical review of research
involving incentives for health promotion. PLoS Med 2012, 9(6):e1001193.
10. Cahill K, Perera R: Competitions and incentives for smoking cessation.
Cochrane Database Syst Rev 2008, 4, CD004986.
11. Diclemente RJ, Young A: Incentivizing drug-using women's long-term
contraceptive use: some answers, more questions. Addiction 2012,
107:1042–1043.
12. Heil SH, Higgins ST: The scientific and ethical rationale for using
incentives to promote contraceptive use among drug-abusing women.
Addiction 2012, 107:1044–1046.
13. Weber A, Tyndall M, Spittal P: High pregnancy rates and reproductive
health indicators among female injection-drug users in Vancouver,
Canada. Eur J Contracept Reprod Health Care 2003, 8(1):52–58.
14. Black KI, Stephens C, Haber PS, Lintzeris N: Unplanned pregnancy and
contraceptive use in women attending drug treatment services.
Aust N Z J Obstet Gynaecol 2012, 52(2):146–150.
15. Read C, Bateson D, Weisberg E, Estoesta J: Contraception and pregnancy
then and now: examining the experiences of a cohort of mid age
Australian women. Aust N Z J Public Health 2009, 49(4):429–433.
16. Taft A, Hobbs M, Hussainy S, Amir L, Stewart K, Smith A, Shelley J, Chapman
C: Unintended pregnancy in Australia: what more can we do? Med J Aust
2011, 195(4):166–167.
17. Minozzi S, Amato L, Vecchi S, Davoli M: Maintenance agonist treatments
for opiate dependent pregnant women (Review). Cochrane Collaboration
2011, 10:CD006318. http://www.gacguidelines.ca/site/GAC_Guidelines/
assets/pdf/200_Minozzi_2008_Cochrane.pdf.
Olsen et al. BMC Women's Health 2014, 14:5 Page 8 of 8
http://www.biomedcentral.com/1472-6874/14/518. Fajemirokun-Odudeyi O, Sinha C, Tutty S, Pairaudeau P, Armstrong D,
Phillips T, Lindow S: Pregnancy outcome in women who use opiates.
Eur J Obstet Gynecol Reprod Biol 2006, 126(2):170–175.
19. Ludlow JP, Evans SF, Hulse G: Obstetric and perinatal outcomes in
pregnancies associated with illicit substance abuse. Aust N Z J Obstet
Gynaecol 2004, 44(4):301–306.
20. Hulse G, English D, Milne E, Holman D, Bower C: Maternal cocaine use and
low birthweight newborns: a meta-analysis. Addiction 1997, 92:1561–1570.
21. Wilkinson R, Marmot M: Social determinants of health: the solid facts. 2nd
edition. WHO Regional Office for Europe: Denmark; 2003.
22. Tomison A: Child maltreatment and substance abuse. Melbourne: The
National Child Protection Clearing House, Australian Institute of Family
Studies; 1996.
23. Abdel-Latif M, Bajuk B, Lui K, Oei J, NSW on ACT Neonatal Intensive Care
Units' Study (NICUS) Group: Short-term outcomes of infants of
substance-using mothers admitted to neonatal intensive care units in
New South Wales and the Australian Capital Territory. J Paediatr Child
Health 2007, 43(3):127–133.
24. Dawe S, Atkinson J, Frye S, Evans C, Best D, Lynch M, Moss D, Harnett P:
Drug use in the family: impacts and implications for children. Australian
National Council on Drugs: Canberra, ACT; 2007.
25. Battams S, Roche A: Child wellbeing and protection concerns and the
response of the alcohol and other drugs sector in Australia. Adv Mental
Health 2011, 10(1):62–71.
26. Klee H: Drug-using parents: analysing the stereotypes. Int J Drug Pol 1998,
9:437–448.
27. Banwell C, Bammer G: Maternal habits: narratives of mothering and drug
use in Canberra. Int J Drug Pol 2006, 17(6):504–513.
28. Kearney MH, Murphy S, Rosenbaum M: Mothering on crack cocaine: a
grounded theory analysis. Soc Sci Med 1994, 38(2):351–361.
29. Baker P, Carson A: ‘I take care of my kids’: mothering practices of
substance-abusing women. Gend Soc 1999, 13(3):347–363.
30. Olsen A, Banwell C, Dance P, Maher L: Positive health beliefs and
behaviours in the midst of difficult lives: women who inject drugs.
Int J Drug Pol 2012, 23:312–318.
31. NSW Department of Health: National clinical guidelines for the management
of drug use during pregnancy, birth and the early development years of the
newborn. Sydney: Commonwealth of Australia; 2006.
32. National Centre in HIV Social Research: C-change. Report of the enquiry into
Hepatitis C related discrimination. Sydney, N.S.W: Anti-Discrimination Board of
New South Wales; 2001.
33. Day C, Ross J, Dolan K: Hepatitis C-related discrimination among heroin
users in Sydney: drug user or hepatitis C discrimination? Drug Alcohol Rev
2003, 22:317–321.
34. Norman R: Have you got an attitude problem? Caring for illicit
drug-using patients. Contemp Nurse 2001, 10:83–91.
35. Miles M, Francis K, Chapman Y: Challenges for midwives: pregnant
women and illicit drug use. Aust J Adv Nurs 2010, 28(1):83–90.
36. Kaltenbach K, Berghella V, Finnegan L: Opioid dependence during
pregnancy: effects and management. Obstet Gynecol Clin N Am 1998,
25:139–151.
37. Gray E, McDonald P: Contraceptive practice and the reproductive life
course. In HILDA Survey Research Conference. Melbourne: University of
Melbourne; 2007.
38. Banwell C, Bammer G, Main N, Gifford S, O'Brien M: Disturbingly low levels
of contraception among women living with hepatitis C. Aust NZ J Public
Health 2003, 27(6):620–626.
39. Santelli J, Rochat R, Hatfield-Timajchy K, Colley Gilbert B, Curtis K, Cabral R,
Hirsch J, Schieve L, Other Members of the Unintended Pregnancy Working
Group: The measurement and meaning of unintended pregnancy.
Perspect Sex Reprod Health 2003, 35(2):94–101.
40. Bachrach CA, Newcomer S: Intended pregnancies and unintended
pregnancies: distinct categories or opposite ends of a continuum?
Fam Plan Perspect 1999, 31(5):251–252.
41. Luker KC: A reminder that human behavior frequently refuses to
conform to models created by researchers. Fam Plan Perspect 1999,
31(5):248–249.
42. Muhr T, Friese S: Users manual for ATLAS.ti 5.0. Berlin: Scientific Software
Development; 2004.43. Olsen A, Banwell C, Dance P: Internal or infernal devices: experiences of
contraception among Australian women living with hepatitis C. Health
Care Women Int 2009, 30(6):456–474.
44. Banwell C, Dance P, Olsen A, Dixon J: “It fucks your insides up”: the effects
of Australian urban women’s opioid use on their sexual & reproductive
functioning. Women's Health Urban Life 2009, 8(1):14–27.
45. Gray E, McDonald P: Using a reproductive life course approach to understand
contraceptive method use in Australia. J Biosoc Sci 2010, 42(1):43–57.
46. Mills A, Barclay L: None of them were satisfactory: women's experiences
with contraception. Health Care Women Int 2006, 27(5):379–398.
47. Byrne I: She just adored the ground I walked on: challenging dominant
discourses of injecting drug-using parents. 2010. unpb BSS honours
thesis RMIT.
48. Richter K, Bammer G: A hierarchy of strategies heroin-using mother employ
to reduce harm to their children. J Subst Abus Treat 2000, 19:403–413.
49. Colten M: Attitudes, experience and self-perceptions of heroin addicted
mothers. J Soc Issues 1982, 38:72–92.
50. Banwell C: 'Methadone mothers': converging drug and mothering
discourses and identities. Sites NS 2003, 1(1):133–160.
51. Taylor A: Women drug users: an ethnography of a female injecting
community. Oxford: Oxford University Press; 1993.
52. Murphy S, Rosenbaum M: Pregnant women on drugs: combating stereotypes
and stigma. New Jersey: Rutgers University Press; 1998.
53. Parr V, Bullen J: AIVL National anti-discrimination project. Canberra: Australian
Injecting and Illicit Drug Users' League (AIVL); 2010.
54. Edlin B, Kresina T, Raymond D, Carden M, Gourevitch M, Rich J, Cheever LW,
Cargill VA: Overcoming barriers to prevention, care, and treatment of
hepatitis C in illicit drug users. Clin Infect Dis 2005, 40(5):S276–S285.
55. Swift W, Copeland J: Treatment needs and experience of Australian
women with alcohol and other drug problems. Drug Alcohol Depend
1996, 40:211–219.
56. Treloar C, Abelson J, Cao W, Brener L, Kippax S, Schultz L, Schultz M, Bath N,
National Centre in HIV Social Research, LMS Consulting, et al: Barriers and
incentives to treatment for illicit drug users. National drug strategy monograph
series no. 53. Australian Government Department of Health and Ageing:
Canberra; 2004.
57. Rowe J: Who's Using? The health information exchange [St Kilda] and the
development of an innovative primary health care response for injecting drug
users. Salvation Army Crisis Services: Melbourne; 2003.
58. Dietze P, Stoové M, Miller P, Kinner S, Bruno R, Alati R, Burns L: The self-
reported personal wellbeing of a sample of Australian injecting drug
users. Addiction 2010, 105(12):2141–2148.
59. Emmett GA: What happened to the 'crack babies'. Drug Policy Anal Bull
1998, 4:1–3. February edn.
60. Ettorre E: Revisioning women and drug use: gender sensitivity,
embodiment and reducing harm. Int J Drug Policy 2004, 15:324–335.
61. Maher L: Sexed work: gender, race and resistance in a Brooklyn drug market.
Oxford: Clarendon Press; 1997.
62. Maher L: Don't leave us this way: ethnography and injecting drug use in
the age of AIDS. Int J Drug Policy 2002, 13:311–325.
63. Bourgois P, Prince B, Moss A: The everyday violence of hepatitis C among
young women who inject drugs in San Francisco. Hum Organ 2004,
63(3):253–264.
64. Shatila S, MacMaster S, Jones J, Chaffin K: C.R.A.C.K: Unethical? What about
misogynist, racist and classist? J Afr Am Stud 2005, 9:32–42.
doi:10.1186/1472-6874-14-5
Cite this article as: Olsen et al.: Contraception, punishment and women
who use drugs. BMC Women's Health 2014 14:5.
